Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last SFr.1.26 CHF
Change Today -0.02 / -1.56%
Volume 6.6M
As of 2:10 PM 10/2/15 All times are local (Market data is delayed by at least 15 minutes).

evolva holding sa (EVE) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/28/15 - SFr.1.75
52 Week Low
09/29/15 - SFr.0.96
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for EVOLVA HOLDING SA (EVE)

Related News

No related news articles were found.

evolva holding sa (EVE) Related Businessweek News

No Related Businessweek News Found

evolva holding sa (EVE) Details

Evolva Holding SA, a biosynthetic company, discovers, develops, manufactures, and commercializes ingredients for nutrition, health care, and wellness products in Switzerland and internationally. The company’s principal products include Resveratrol, a natural compound produced in grapes and other plants as a response against environmental stress factors; Vanillin, a complex blend of compounds extracted from the seed pods of the vanilla orchid; and Stevia, a natural, zero-calorie food, and beverage sweetener derived from Stevia rebaudiana, a leafy green plant for family. It also offers Nootkatone, a citrus ingredient associated with grapefruits, which is used as a flavor and fragrance ingredient; and as agent against a range of insect pests, including ticks, bed bugs, and mosquitoes. In addition, the company provides Agarwood for perfume makers and traditional medicine practitioners; Saffron, a spice made by yeast fermentation; Valencene, an orange flavor and fragrance ingredient used in food and drink, personal care, and household products, as well as an intermediate to produce nootkatone; and Sandalwood, an oil used in preparing various types of perfume compositions. Further, it offers legacy products, such as EV-077, a compound for diabetic nephropathy and other diabetic complications; EV-35, a preclinical antibiotic; and Pomecins, an antifungal ingredient that prevent mould and yeast growth. The company is based in Reinach, Switzerland.

154 Employees
Last Reported Date: 08/25/15

evolva holding sa (EVE) Top Compensated Officers

Co-Founder, Chief Executive Officer and Direc...
Total Annual Compensation: SFr.388.7K
Compensation as of Fiscal Year 2014.

evolva holding sa (EVE) Key Developments

Evolva Holding SA. Presents at The Investora Zurich 2015, Sep-30-2015 08:30 AM

Evolva Holding SA. Presents at The Investora Zurich 2015, Sep-30-2015 08:30 AM. Venue: Zurich, Switzerland. Speakers: Jakob Dynnes Hansen, Chief Financial Officer.

Evolva Holding SA. Presents at Berenberg Specialty Chemicals & Food Ingredients, Oct-01-2015

Evolva Holding SA. Presents at Berenberg Specialty Chemicals & Food Ingredients, Oct-01-2015 . Venue: Berenberg Offices, 60 Threadneedle Street, London EC2R 8HP, United Kingdom. Speakers: Neil Goldsmith, Co-Founder, Chief Executive Officer and Director.

Evolva Holding Has No Current Plans For Acquisitions, But May Consider Later

Evolva Holding SA. (SWX:EVE) stated that it has no current plans for acquisitions, it may at a later stage consider an acquisition as the most effective way of progressing its projects and strategy.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EVE:SW SFr.1.26 CHF -0.02

EVE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
GLG Life Tech Corp C$0.33 CAD +0.045
Ingredion Inc $88.98 USD +1.82
PureCircle Ltd 420.00 GBp 0.00
Stevia First Corp $0.10 USD -0.005
View Industry Companies

Industry Analysis


Industry Average

Valuation EVE Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 29.5x
Price/Book 2.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 30.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EVOLVA HOLDING SA, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at